174 related articles for article (PubMed ID: 18066078)
1. Pot1 and cell cycle progression cooperate in telomere length regulation.
Churikov D; Price CM
Nat Struct Mol Biol; 2008 Jan; 15(1):79-84. PubMed ID: 18066078
[TBL] [Abstract][Full Text] [Related]
2. Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection.
Churikov D; Wei C; Price CM
Mol Cell Biol; 2006 Sep; 26(18):6971-82. PubMed ID: 16943437
[TBL] [Abstract][Full Text] [Related]
3. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
[TBL] [Abstract][Full Text] [Related]
5. ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres.
Thanasoula M; Escandell JM; Suwaki N; Tarsounas M
EMBO J; 2012 Aug; 31(16):3398-410. PubMed ID: 22842784
[TBL] [Abstract][Full Text] [Related]
6. RPA and POT1: friends or foes at telomeres?
Flynn RL; Chang S; Zou L
Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
[TBL] [Abstract][Full Text] [Related]
7. Pot1 inactivation leads to rampant telomere resection and loss in one cell cycle.
Pitt CW; Cooper JP
Nucleic Acids Res; 2010 Nov; 38(20):6968-75. PubMed ID: 20601686
[TBL] [Abstract][Full Text] [Related]
8. Apollo contributes to G overhang maintenance and protects leading-end telomeres.
Wu P; van Overbeek M; Rooney S; de Lange T
Mol Cell; 2010 Aug; 39(4):606-17. PubMed ID: 20619712
[TBL] [Abstract][Full Text] [Related]
9. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
[TBL] [Abstract][Full Text] [Related]
10. Activation of the S phase DNA damage checkpoint by mitomycin C.
Mladenov E; Tsaneva I; Anachkova B
J Cell Physiol; 2007 May; 211(2):468-76. PubMed ID: 17167777
[TBL] [Abstract][Full Text] [Related]
11. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
Stojic L; Mojas N; Cejka P; Di Pietro M; Ferrari S; Marra G; Jiricny J
Genes Dev; 2004 Jun; 18(11):1331-44. PubMed ID: 15175264
[TBL] [Abstract][Full Text] [Related]
13. Benzo[a]pyrene induces complex H2AX phosphorylation patterns by multiple kinases including ATM, ATR, and DNA-PK.
Yan C; Lu J; Zhang G; Gan T; Zeng Q; Shao Z; Duerksen-Hughes PJ; Yang J
Toxicol In Vitro; 2011 Feb; 25(1):91-9. PubMed ID: 20888899
[TBL] [Abstract][Full Text] [Related]
14. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
15. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
Rodríguez-Bravo V; Guaita-Esteruelas S; Florensa R; Bachs O; Agell N
Cancer Res; 2006 Sep; 66(17):8672-9. PubMed ID: 16951182
[TBL] [Abstract][Full Text] [Related]
16. Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance.
Bi X; Srikanta D; Fanti L; Pimpinelli S; Badugu R; Kellum R; Rong YS
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15167-72. PubMed ID: 16203987
[TBL] [Abstract][Full Text] [Related]
17. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
[TBL] [Abstract][Full Text] [Related]
18. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CHK1 kinase by Gö6976 converts 8-chloro-adenosine-induced G2/M arrest into S arrest in human myelocytic leukemia K562 cells.
Jia XZ; Yang SY; Zhou J; Li SY; Ni JH; An GS; Jia HT
Biochem Pharmacol; 2009 Mar; 77(5):770-80. PubMed ID: 19059218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
